Archives

by in
Entry Author Date Location
Genentech Cancer Antibody, Son of Rituxan, Nails Pivotal Study 05/15/13 San Francisco
Opexa Tries a Personalized Cell Therapy Against Last, Worst Stage of MS 05/02/13 Texas
Big Data Is BS in Healthcare. When Will It Become Real? 04/15/13 National
Boston Biotech Seizes the Momentum: The Photos 04/08/13 Boston
Gilead Sciences Building on HIV, Becoming Cancer Drug Force 04/01/13 National
East Coast Biotech Roundup: Biogen Idec, Third Rock, T2 Bio, Dart 03/29/13 Boston
Biogen Idec Wins FDA Approval For Oral Multiple Sclerosis Drug 03/27/13 Boston
Allozyne Conducts Round of Employee ‘Furloughs’ 03/15/13 Seattle
Boston Biotech Seizes the Momentum: Last Chance for Early Bird Tix 03/07/13 Boston
Someone Needs to Rank U.S. Biotech Hubs, For Real 03/04/13 National
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
East Coast Life Sciences Roundup: Biogen Idec, Celgene, Alnylam, More 02/08/13 Boston
Boston Roundup: Biogen Idec, Cloudant, NEA, eClinicalWorks, & More 02/06/13 Boston
Biogen ALS Failure Highlights Clinical Trial Frustrations 01/10/13 Boston
East Coast Life Sciences Roundup: Pfizer, J&J, Alkermes, More 01/04/13 Boston
Biogen Idec’s ALS Drug Fails Phase III Trial 01/03/13 Boston
Isis Pharmaceuticals Adds More Deals to Partnership Portfolio 12/12/12 San Diego
Tantalizing Hints of Progress Against ALS for Cytokinetics, Others 11/14/12 San Francisco
LinkedIn: The Quiet Force Transforming Biotech & Pharma 11/05/12 National
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Who Should Life Science Pros Follow on Twitter? 09/24/12 National
Biotech Begins to Come of Age on Twitter 09/17/12 National
Fearless Football and Biotech Picks For Fall 2012 09/04/12 National
IPOs, Biogen, Northeastern, & More From the Boston Life Sciences Roundup 08/17/12 Boston
San Diego Life Sciences Roundup: Regulus, MEI Pharma, Qualcomm & More 08/16/12 San Diego
Biogen Idec, Regulus Cut Deal to Monitor Multiple Sclerosis 08/15/12 San Diego
Biogen Idec, Isis Forge 2nd Alliance This Year for Rare Disease 06/29/12 Boston
Clash of the BioPharma Titans Looms Over Biosimilars 06/25/12 National
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers 05/21/12 National
Cytokinetics Shows Hint of Effect With Drug for Lou Gehrig’s Disease 04/25/12 San Francisco
Page 1 of 15 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  2. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.